An experimental gene therapy for high cholesterol is showing promise in clinical trials and inching closer to approval. The treatment, called VERVE-102, is being tested in people with familial hypercholesterolemia (FH), an inherited condition that raises the levels of low-density lipoprotein (LDL) cholesterol — the “bad” kind — in the blood. It’s also being tested in people with premature coronary …
Read More »Experimental treatment for high cholesterol edits DNA in the body to reduce LDL
